Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05617053

DAART vs PTA/SUPERA STENTING FOR POPLITEAL ARTERY LESIONS

Conditions: Popliteal Artery Stenosis, Atheroma

Sex: All
Ages: 18 Years – 99 Years
Enrollment: 143
Sponsor: Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery

Summary

The purpose of this study was to compare the results of directional atherectomy with antirestenotic therapy (DAART technique) and angioplasty/Supera stenting for the treatment of popliteal atherectomy lesions.

Eligibility Criteria

Inclusion Criteria:patients with lifestyle limiting intermittent claudication ischemic rest pain, ischemic ulcers or gangrene (Rutherford class 3 to 6) who presented atherosclerotic lesions in the popliteal artery undergoing endovascular treatment by DAART of PTA/Supera stenting and at least a 12-months of follow-upExclusion Criteria:Exclusion criteria were patients who could not receive antiplatelet or anticoagulation therapies. Other exclusion criteria were patients with aneurysm of the ipsilateral superficial femoral artery or popliteal artery, acute thrombus, unsalvageable limb, very limited life-expectancy or with doubts in their willingness or capability to allow follow-up examinations.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05617053). StuddyBuddy aggregates publicly available trial information.